Targeting ferroptosis as a potential strategy to overcome the resistance of cisplatin in oral squamous cell carcinoma
Frontiers in Pharmacology · 22.04.2024 · 15
DOI: 10.3389/fphar.2024.1402514 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 22.04.2024. Verfasst von Rongkun Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Yunnan Key Laboratory of Stomatology, School of Stomatology, Kunming Medical University, Kunming, China. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Oral squamous cell carcinoma (OSCC) is a crucial public health problem, accounting for approximately 2% of all cancers globally and 90% of oral malignancies over the world. Unfortunately, despite the achievements in surgery, radiotherapy, and chemotherapy techniques over the past decades, OSCC patients still low 5-year survival rate. Cisplatin, a platinum-containing drug, serves as one of the first-line chemotherapeutic agents of OSCC. However, the resistance to cisplatin significantly limits the clinical practice and is a crucial factor in tumor recurrence and metastasis after conventional treatments. Ferroptosis is an iron-based form of cell death, which is initiated by the intracellular accumulation of lipid peroxidation and reactive oxygen species (ROS). Interestingly, cisplatin-resistant OSCC cells exhibit lower level of ROS and lipid peroxidation compared to sensitive cells. The reduced ferroptosis in cisplatin resistance cells indicates the potential relationship between cisplatin resistance and ferroptosis, which is proved by recent studies showing that in colorectal cancer cells. However, the modulation pathway of ferroptosis reversing cisplatin resistance in OSCC cells still remains unclear. This article aims to concisely summarize the molecular mechanisms and evaluate the relationship between ferroptosis and cisplatin resistance OSCC cells, thereby providing novel strategies for overcoming cisplatin resistance and developing new therapeutic approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Yunnan Key Laboratory of Stomatology, School of Stomatology, Kunming Medical University, Kunming, China.
- Department of Periodontology, Kunming Medical University School and Hospital of Stomatology, Kunming Medical University, Kunming, China.
- Department of Oral Implantology, Kunming Medical University School and Hospital of Stomatology, Kunming Medical University, Kunming, China.
Zitieren
APA
Chen, R., Zhu, S., Zhao, R., Liu, W., Jin, L., Ren, X., & He, H. (2024). Targeting ferroptosis as a potential strategy to overcome the resistance of cisplatin in oral squamous cell carcinoma. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1402514
Vancouver
Chen R, Zhu S, Zhao R, Liu W, Jin L, Ren X, et al. Targeting ferroptosis as a potential strategy to overcome the resistance of cisplatin in oral squamous cell carcinoma. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1402514
BibTeX
@article{Chen2024,
author = {Chen, Rongkun and Zhu, Shuyu and Zhao, Ruoyu and Liu, Wang and Jin, Luxin and Ren, Xiaobin and He, Hongbing},
title = {Targeting ferroptosis as a potential strategy to overcome the resistance of cisplatin in oral squamous cell carcinoma},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {15},
doi = {10.3389/fphar.2024.1402514}
}
EUVIMED